Understand Peripheral Artery Disease (PAD) and its link with hypertension. Learn about the causes, symptoms, and risks ...

Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Patients with worse glaucoma severity were more likely to experience steroid-induced ocular hypertension, according to a ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Intensive blood pressure management may lower the risk of developing dementia or cognitive impairment without dementia.

The pulmonary arterial hypertension (PAH) drug preserved its safety profile at 2.5 years of treatment and continued to reduce ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease.

Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 ...

Kauvery Hospital launches Pulmonary Hypertension clinic for comprehensive care, early diagnosis, and multidisciplinary ...

Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in ...

Life in Kiribati, an island nation in the central Pacific Ocean, is influenced by its remote location, high disease burden ...

Keros will be down to 85 full-time employees after the layoffs and expects to generate annualized savings of $17 million.